Thoma Achilleas, Jansen Leigh, Sprague Sheila, P Stat Eric Duku
Department of Surgery, Division of Plastic and Reconstructive Surgery, St Joseph's Healthcare, Hamilton, Ontario.
Can J Plast Surg. 2008 Summer;16(2):77-84. doi: 10.1177/229255030801600201.
To perform a cost-effectiveness analysis comparing the superficial inferior epigastric artery (SIEA) and deep inferior epigastric perforator (DIEP) flaps in postmastectomy reconstruction.
A decision analytic model with seven clinically important health outcomes (health states) was used, incorporating the Ontario Ministry of Health's perspective. Direct medical costs were estimated from a university-based hospital. The utilities of each health state converted into quality-adjusted life years (QALYs) were obtained from previously published data. Health state probabilities were computed from a systematic literature review. Analyses yielded SIEA and DIEP expected costs and QALYs allowing calculation of the incremental cost-utility ratio (ICUR). One-way sensitivity analyses were conducted under five plausible scenarios, assessing result robustness.
Five SIEA and 27 DIEP studies were identified. The baseline SIEA expected cost was slightly higher than that for the DIEP ($16,107 versus $16,095), with slightly higher QALYs (33.14 years versus 32.98 years), giving an ICUR of $77/QALY. Taking into account conversions from SIEA to DIEP, the ICUR increased to $4,480/QALY. Sensitivity analysis gave ICURs ranging from $2,614/QALY to 'dominant', all consistent with the adoption of the SIEA over the DIEP.
The best available evidence suggests the SIEA is a cost-effective procedure. However, given the high SIEA to DIEP conversion rates and small marginal differences in cost and effectiveness, the ICUR may be sensitive to minor changes in costs or QALYs. The 'truth' can only be obtained from a randomized, controlled trial comparing both techniques side by side, simultaneously capturing the costs of the competing interventions.
进行一项成本效益分析,比较乳房切除术后重建中腹壁浅动脉(SIEA)皮瓣和腹壁下深动脉穿支(DIEP)皮瓣。
采用具有七个临床重要健康结局(健康状态)的决策分析模型,纳入安大略省卫生部的观点。直接医疗成本从一家大学附属医院估算得出。每个健康状态转换为质量调整生命年(QALY)的效用值取自先前发表的数据。健康状态概率通过系统文献综述计算得出。分析得出SIEA和DIEP的预期成本及QALY,从而能够计算增量成本效用比(ICUR)。在五种合理情景下进行单向敏感性分析,评估结果的稳健性。
共识别出5项关于SIEA的研究和27项关于DIEP的研究。SIEA的基线预期成本略高于DIEP(分别为16,107美元和16,095美元),QALY略高(分别为33.14年和32.98年),ICUR为77美元/QALY。考虑从SIEA转换为DIEP的情况后,ICUR增至4,480美元/QALY。敏感性分析得出的ICUR范围从2,614美元/QALY到“优势”,均表明采用SIEA优于DIEP。
现有最佳证据表明SIEA是一种具有成本效益的手术方法。然而,鉴于SIEA向DIEP的高转换率以及成本和效益方面的微小边际差异,ICUR可能对成本或QALY的微小变化敏感。只有通过一项将两种技术并排比较的随机对照试验,同时获取竞争性干预措施的成本,才能得出“真实情况”。